We are live on ! Find out more
INDP icon

Indaptus Therapeutics
INDP

26 hedge funds and large institutions have $2.03M invested in Indaptus Therapeutics in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

75% more capital invested

Capital invested by funds: $1.16M → $2.03M (+$873K)

30% more funds holding

Funds holding: 20 → 26 (+6)

Holders
26
Holders Change
+6
Holders Change %
+30%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
2
Closed
3
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$6K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$228K
2
IWC
Integrated Wealth Concepts
Massachusetts
+$114K
3
HIIFS
Harel Insurance Investments & Financial Services
Israel
+$101K
4
Citadel Advisors
Citadel Advisors
Florida
+$48.2K
5
Squarepoint
Squarepoint
New York
+$33.4K

Top Sellers

Rank Fund Capital Flow
1
PF
Phoenix Financial
Israel
-$112K
2
EMG
ETF Managers Group
New Jersey
-$72K
3
Morgan Stanley
Morgan Stanley
New York
-$9.27K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4.33K
Name Holding Trade Value Shares
Change 		Change in
Stake
EMG
26
ETF Managers Group
New Jersey
– -$72K -148 Closed
1
2

INDP Hedge Fund Activity: Q2 2020 in Review

26 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q2 2020, worth a combined $2.03M — up 75% from $1.16M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new INDP positions and 3 closed out — a net gain of 6 holders — while 7 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $228K. The largest seller was Phoenix Financial, exiting entirely with an estimated $112K sold.

  • 26 institutional investors held Indaptus Therapeutics (INDP) as of Q2 2020, up from 20 in Q1 2020.
  • Funds reported $2.03M of Indaptus Therapeutics stock for Q2 2020, up 75% quarter-over-quarter.
  • 9 funds opened new Indaptus Therapeutics positions in Q2 2020 and 3 closed out, a net change of +6 holders.
  • The largest Indaptus Therapeutics buyer in Q2 2020 was Renaissance Technologies, an estimated $228K added.
  • The largest Indaptus Therapeutics seller in Q2 2020 was Phoenix Financial, an estimated $112K sold.

Based on aggregated 13F filings for Q2 2020.